FDA to convene VRBPAC on vaccines for younger children plus Moderna, J&J boosters
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaProduct LifecycleRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaProduct Lifecycle